NASDAQ · HSCS
HeartSciences Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for HSCS: Dec 21, 2026
HeartSciences Inc. Common Stock is estimated to report earnings on 12/21/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 2 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.74. The reported EPS for the same quarter last year was $-0.85.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Oct 2026 | $-0.74 | $-0.72 | $-0.76 | 2 |
| Jan 2027 | $-0.75 | $-0.70 | $-0.80 | 2 |
| Apr 2027 | $-0.73 | $-0.64 | $-0.82 | 2 |
| Jul 2027 | $-0.65 | $-0.65 | $-0.65 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · RTTNews- Zacks · Oct 22, 8:40 AM EDTIs HeartSciences Inc. (HSCS) Stock Outpacing Its Medical Peers This Year?Here is how HeartSciences Inc. (HSCS) and ImmunityBio (IBRX) have performed compared to their sector so far this year.
- RTTNews · Oct 21, 4:11 PM EDTBiotech Stocks Move Higher: IMNN Surges Over 18%, HSCS Gains Over 13%, SXTC Rises 7%(RTTNews) – Shares of several small-cap companies moved higher on Wednesday following corporate developments involving a proposed digital asset mining merger, a strategic drug asset sale and changes to securities offering terms. Imunon announced an agreement to sell its ThermoDox
- Zacks · Oct 14, 8:12 AM EDTHere's How Quest Diagnostics Is Placed Ahead of Q3 EarningsDGX heads into Q3 earnings with expected revenue and EPS growth, fueled by strong clinical demand, advanced diagnostics and operational efficiencies.
- Zacks · Oct 13, 9:25 AM EDTThermo Fisher to Report Q3 Earnings: What's in the Cards?TMO gears up for Q3 earnings, with revenue and EPS growth expected amid strong bioproduction demand, product innovations and clinical research strength.
- RTTNews · Oct 9, 1:37 PM EDTWeekly Buzz: RHHBY, NVS, PFE Win FDA Nod; CRBU Scales Back; PCVX, ABBV Report Positive Trial Data(RTTNews) – This week, biopharmaceutical companies saw a busy week of regulatory decisions, strategic partnerships and clinical developments, alongside pipeline setbacks and workforce reductions.
- RTTNews · Oct 6, 9:29 AM EDTHeartSciences Wins FDA Clearance For MyoVista WavECG; Fortitude Lines Up $100 Mln Miner Deal(RTTNews) – HeartSciences Inc. (HSCS), a healthcare technology company, said the FDA has granted 510(k) clearance for its MyoVista wavECG device. The company had submitted the device for 510(k) review in December 2025.
- RTTNews · Oct 6, 8:57 AM EDTHeartSciences' MyoVista WavECG Device Gets FDA 510(k) Clearance(RTTNews) – HeartSciences (HSCS) said it received FDA 510(k) clearance for its MyoVista wavECG device, advancing the company's efforts to commercialize its artificial intelligence (AI)-enabled ECG technology.
- RTTNews · Sep 21, 9:35 AM EDTBiotech Stocks At 52-Week Highs – HSCS +7%, FRNM +5%, VOGX, HTFL, HALO(RTTNews) – The following biotech stocks reached a 52-week high on September 18, 2026, driven by the gain on certain clinical trial results or an announced public offering.
- RTTNews · Sep 17, 8:42 AM EDTFortitude Mining Appoints Jaime Leverton As CEO(RTTNews) – Fortitude Mining Holdings, Inc., a digital asset miner, said on Thursday that it has appointed Jaime Leverton as chief executive officer with effect from September 21.
- RTTNews · Sep 15, 11:35 AM EDTHeartSciences FQ1 Loss Widens; MyoVista Gains Traction, Fortitude Deal Advances(RTTNews) – HeartSciences Inc. (HSCS) reported fiscal first-quarter 2027 financial results and a business update, highlighting continued commercial progress for its MyoVista Insights platform and advancement of its proposed business combination with Fortitude Mining Holdings.
- Zacks · Sep 14, 5:35 PM EDTHeartSciences Inc. (HSCS) Reports Q1 Loss, Misses Revenue EstimatesHeartSciences Inc. (HSCS) delivered earnings and revenue surprises of -10.26% and -97.90%, respectively, for the quarter ended July 2026. Do the numbers hold clues to what lies ahead for the stock?
- RTTNews · Aug 19, 11:27 AM EDTFortitude Invests $1 Million In HeartSciences At 22% Premium; Stock Up(RTTNews) – HeartSciences Inc. (HSCS), a healthcare information technology company advancing electrocardiography through artificial intelligence, announced that Fortitude Mining Holdings, Inc. has invested $1 million in the company at a 22% premium to market price.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for HeartSciences Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.